MM285.design.tsv.gz
has two columns, Probe_ID and design, one row per probe on the
296,070-probe design-paper manifest. The design field lists every group the probe was selected for,
separated by commas. A probe picked by two strategies carries both, for example
CTCF,EPIC;cg04056615. Within a group entry, semicolons separate the group name from its details, such as
the syntenic human EPIC probe or the nearest TSS. The last column of each table below shows that format.
The same groups are distributed as the knowYourCG (v1) knowledgebase KYCG.MM285.designGroup.20210210
(ExperimentHub EH6825, getDBs("MM285.designGroup")). The design and the selection criteria are described
in Zhou et al. 2022 [1]. This page adds the criteria from the original selection code where the paper is
silent, and notes where the two differ.
Every CpG group draws from one list of designable CpGs [1]. For each CpG in mm10, both Infinium-I probe designs on the converted strand were aligned with BISCUIT. A design was kept only if its 30-, 35- and 40-nt 3′ subsequences and the full probe all map uniquely, with mapping quality above 20 for both alleles. Designs were then dropped if a SNP from 15 laboratory strains [2] or another CpG lay within 10 nt of the 3′ end, or if the probe held six or more CpGs. A design score for GC content and melting temperature had to exceed 0.3. About 9.77 million CpGs passed. Some groups draw from a stricter high-quality subset.
| Group | Probes | Source | Selection | Detail format |
|---|---|---|---|---|
| TSS | 69,237 | Ensembl release 96 protein-coding transcripts, collapsed to 54,376 TSSs [3] | Designable CpGs within 1,500 bp of a TSS, ranked by distance. Lower-quality designs (score under 0.6) carry a 500 bp penalty. At most two CpGs per TSS. 1,972 TSSs (3.6%) have no designable CpG. | TSS;chr:pos;gene;transcript;distance;rank |
| lincRNATSS | 12,029 | Ensembl 96 lincRNA TSSs (8,621) [3] | At most two CpGs per TSS, closest first. 1,327 lincRNA TSSs have no designable CpG. | lincRNATSS;chr:pos;gene;transcript;distance |
| PseudogeneTSS | 10,244 | Ensembl 96 pseudogene TSSs [3] | Closest designable CpG to each TSS. | PseudogeneTSS;chr:pos;gene;transcript;distance |
| miRNA | 3,970 | Ensembl 96 miRNA transcripts [3] | Closest designable CpGs to each transcript start. | miRNA;chr:pos;gene;transcript;distance;rank |
| CGI | 17,134 | UCSC mm10 CpG islands | One CpG for each island at an Ensembl TSS, three for each island away from any TSS. Covers 13,365 of 16,023 islands. | CGI;chr:beg-end |
| GeneBody | 24,638 | RefSeq canonical protein-coding transcripts [4] | One random CpG per transcript, from 2 kb downstream of the TSS to the transcription end, excluding 5′ CpG islands. Transcripts shorter than 2 kb were skipped. | GeneBody;gene;RefSeq;location;splice=0|1 |
| Enhancer | 58,759 | ChromHMM enhancer states (strong and poised) in mouse ESCs [5] and adult tissues [6]; 176 public WGBS methylomes (paper Table S1) | High-quality CpGs in an enhancer state and over 1 kb from a protein-coding TSS. Kept if methylated (>0.7) in at least five methylomes and unmethylated (<0.3) in at least five, which left 757,439 tissue-variable CpGs. 30,000 were sampled from CpGs in three or more enhancer calls and 30,000 from the rest. | Enhancer |
| EnhancerVista | 1,245 | VISTA Enhancer Browser, experimentally validated enhancers [7] | High-quality CpGs inside validated mouse enhancer elements. | EnhancerVista;chr:beg-end |
| CTCF | 8,616 | Mouse ENCODE CTCF ChIP-seq, 19 tissues [8], checked against ChromHMM [6] | CpGs inside CTCF peaks in at least two tissues. They were binned by the fraction of compendium methylomes in which they are unmethylated (<0.2), and up to 1,000 were sampled per bin. Sites methylated in every sample were dropped. | CTCF |
| EPIC | 29,008 | Human MethylationEPIC CpGs [9], UCSC liftOver to mm10 | EPIC CpGs that lift over to a designable mouse CpG. 28,719 map uniquely in both genomes. The mouse probe sequence differs from the human one. The set is promoter-rich because EPIC is. | EPIC;<EPIC probe ID> |
| Group | Probes | Source | Selection | Detail format |
|---|---|---|---|---|
| MonoallelicMeth | 7,813 | WGBS compendium, excluding germ-cell and early-embryo samples | Autosomal CpGs measured in more than six samples and intermediately methylated (0.35 to 0.65) in over 65% of them. Intended to capture imprinting and other mono-allelic methylation. | MonoallelicMeth |
| ImprintDMR | 623 | 26 curated imprinted regions (paper key resources table) | High-quality CpGs inside known imprinting control regions and secondary DMRs. | ImprintDMR;chr:beg-end;allele;DMR name |
| PlacentaIntermed | 981 1 sample | One placenta WGBS sample, Hon et al. 2013, GSM1051161 [10] | Intended for placenta-specific imprinting. CpGs between 0.4 and 0.6 in that sample, about 5.8 million, of which 1,000 were sampled. No comparison with other tissues was made, so the check is the absolute level. It holds in aggregate: the group median is 0.54 across 16 MM285 placentas, against 0.82 in somatic tissue. Per-probe agreement has not been measured. | PlacentaIntermed |
| VMR | 5,835 | Variably methylated IAP elements, Kazachenka et al. 2018 [11] | One CpG for each of 6,402 VM-IAP regions. 633 regions had no designable CpG. | VMR;chr:beg-end |
| PMDsoloWCGW | 5,095 | Common PMDs and solo-WCGW CpGs [12]; lamina-associated domains [13] | Random solo-WCGW CpGs, with no other CpG within 35 bp, inside common PMDs that are also lamina-associated. These CpGs lose methylation with mitotic cell division. | PMDsoloWCGW |
| Adenoma | 8,311 | Colon tumors induced with DSS and azoxymethane, Abu-Remaileh et al. 2015 [14] | CpGs methylated in tumor (>0.7) and unmethylated in normal colon (<0.3). See the note on sample numbers. | Adenoma |
| Clock | 754 | Published mouse epigenetic clocks [15–19] | All designable CpGs of six clocks: Meer 435, Petkovich 90, Stubbs 329, Thompson 273 and 582, and Wang 148. | Clock;<clock>;coefficient |
| RMSK | 4,517 | Repbase consensus sequences [20] | Internal CpGs of rodent-specific repeat families with over 1,000 genomic copies, including 242 probes for IAP and 423 for L1 families. | RMSK;family|class|…;consensus position |
| Mitochondria | 32 | chrM | Mitochondrial CpGs, expected unmethylated, for use as a technical control. | Mitochondria |
The paper's methods describe these groups in one sentence, with no criteria [1]. The criteria below come from the original selection code. Each group compares target samples with the rest of the public WGBS compendium, after dropping methylomes with 15 million or fewer covered CpGs. That filter removed several cited studies, so some groups rest on very few samples. The tags say how many target samples were used and whether the group has been checked on the array.
| Group | Probes | Target samples | Selection |
|---|---|---|---|
| PGCMeth | 474 5 samples | Wang et al. 2014 [21]: male and female PGCs, ICM, 2-cell, 4-cell | Either methylated (>0.7) in all five, or above 0.8 in both PGC samples. These CpGs resist the global demethylation of early development. Not testable on the MM285 atlas, which has no PGC or early-embryo profiles. |
| SpermMeth | 397 replicates in testis | Male germline, spermatogonia to sperm, 6 samples: Hammoud et al. 2014 [22] spermatogonia (2), spermatocyte, spermatid and mature sperm; Wang 2014 sperm [21] | Above 0.85 in all but one target sample, below 0.15 in over 80% of other samples, and below 0.3 in at least one zygote. The group is male-germline rather than sperm-specific, despite its name. In the 7 MM285 testis profiles, which contain that whole lineage, 99% of probes gain more than 0.2 over somatic tissue. |
| SpermUnmeth | 208 replicates in testis | Same six male germline samples | Below 0.15 in all but one target sample, above 0.85 in over 80% of other samples, and above 0.7 in at least one zygote. In the 7 MM285 testis profiles, 99% of probes lose more than 0.2. |
| OocyteMeth | 172 1 sample | Wang 2014 oocyte [21] | Above 0.85 in the oocyte and below 0.15 in over 80% of other samples. Not testable on the MM285 atlas, which has no oocyte profiles. |
| OocyteUnmeth | 486 1 sample | Wang 2014 oocyte [21] | Below 0.15 in the oocyte and above 0.85 in over 80% of other samples. Not testable on the MM285 atlas, which has no oocyte profiles. |
| ZygoteMeth | 474 2 samples | Peat et al. 2014 [23]: wild-type and Tet3-knockout zygote | Above 0.75 in both zygotes and below 0.15 in over 80% of other samples. Not testable on the MM285 atlas, which has no zygote profiles. |
| ZygoteUnmeth | 480 2 samples | Same two zygotes | Below 0.15 in both and above 0.85 in over 80% of other samples. Not testable on the MM285 atlas. |
| PlacentaMeth | 485 does not replicate | One placenta sample, Hon 2013, GSM1051161 [10] | Above 0.85 in the placenta and below 0.15 in over 90% of other samples. See known issues. |
| PlacentaUnmeth | 484 does not replicate | Same placenta sample | Below 0.15 in the placenta and above 0.85 in over 90% of other samples. See known issues. |
| Group | Probes | Source | Selection | Detail format |
|---|---|---|---|---|
| Random | 27,999 | Designability list | Random designable CpGs to cover uncharacterized biology. Extra draws on chrX, and every designable chrY CpG, offset the sex chromosomes' loss to the uniqueness filter. | Random |
| CpH | 2,794 | Adult brain WGBS, Guo et al. 2014 [24] | CpA, CpC and CpT sites. Half are methylated in brain, the rest random. Same mapping and design-score filters as CpG probes. | CpH;CA|CC|CT |
| SNP | 1,490 | Mouse Genomes Project, 36 inbred and wild strains [2] | Up to ten SNPs per branch of the strain phylogeny, 591 branch-specific SNPs in all, outside repeats. Used to check genetic background. | SNP;chr:pos;…;REF>ALT;strain;… |
| Control | 4,216 | Illumina and custom control probes | Control probes, including negative and bisulfite-conversion controls. | Control;type |
| Multi | 7,317 | — | Probes intentionally designed to hit several genomic locations. SeSAMe masks them by default. | Multi |
| UK | 4,541 | — | Probes that missed the design objective through sequence mismatch or weak hybridization, with the
uk prefix. SeSAMe masks them by default. | UK;reason |
KYCG.MM285.designGroup.20210210 (EH6825) and the same labels in MM285.design.tsv.gz.
PlacentaMeth probes gain no methylation in placenta: the median
change is 0.00, the same as random probes with similar somatic methylation. PlacentaUnmeth probes lose
less methylation than comparable highly methylated CpGs, with a median drop of 0.06 against 0.21. The labels are not
swapped, since neither direction holds. Exclude both groups from any placenta-specific interpretation.
kycg) catalogue, so v2 is unaffected. Reported by a user.